ClinicalTrials.gg
RecruitingNCT05814497SCPUpdated Jun 5, 2026

Supraspinal Processing of Sensory Aspects of Pain

An interventional study of Multisensory Task and Graphesthesia in Migraine in Children, Complex Regional Pain Syndromes and Musculoskeletal Pain, sponsored by Children's Hospital Medical Center, Cincinnati. Recruiting at 1 site in United States. Open to participants aged 10 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Children's Hospital Medical Center, Cincinnati · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started May 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
255
Allocation
Not applicable
Ages
10 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 88 studies in Complex Regional Pain Syndromes with a site in United States — 20 open to participants now, 22 under way, 2 of them phase 3. Complex Regional Pain Syndromes · United States.

Planned enrollment
5th of 67
255 · median 30
Started
2023
with 6 others
No phase
36 of 88
10 open now
Primary completion
2027-06
later than 10 of 21 live
Registered
72nd of 88
by date
Lead sponsor
3 of 88
Children's Hospital Medical Center, Cincinnati

Among the 88 studies in Complex Regional Pain Syndromes with a site in United States, this one is the 5th largest by planned enrollment of the 67 interventional ones that give a count, is one of 7 that started in 2023, is one of 36 with no phase, reaches primary completion later than 10 of the 21 other live ones, and was the 72nd registered.

Complex Regional Pain Syndromes

206 studies on the registry are indexed under Complex Regional Pain Syndromes; 54 are open to participants now.

Browse Complex Regional Pain Syndromes studies →

Open to participants now

20 of the 88 studies in Complex Regional Pain Syndromes with a site in United States are open now. Recruiting first, the newest first:

14 more — sign in →

All 20 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 41 Complex Regional Pain Syndromes studies recruiting now, 19 (46%) set no upper age limit and 16 (39%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.

This study: 10 Years to 17 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 88 studies in Complex Regional Pain Syndromes with a site in United States, or all of them as a file.
02

Study summary

The goal of this basic science study is to learn about the brain mechanisms of chronic pain across different chronic pain syndromes in pediatric patients. The main questions it aims to answer are:

  • Are there shared and distinct brain systems engaged by different forms of pediatric chronic pain?
  • What are predictors of recovery from chronic pain?
  • What brain systems are associated with the spread of pain?

For this study participants will undergo:

  • Functional Magnetic Resonance Imaging (fMRI)
  • Quantitative Sensory Testing
  • Psychological Assessments
Read the detailed description

Chronic pain affects approximately 20% of both adults and children in the US and is a source of substantial disability and health care costs. Chronic pain can be challenging to diagnose due to the presence of poorly understood symptoms. When diagnosed, current pharmacologic treatments for pain are remarkably ineffective, while effective non-pharmacologic treatments remain under-utilized. These shortcomings in the diagnosis and treatment of pain arise from tremendous gaps in our knowledge about the basic central nervous system systems that process nociceptive information and instantiate an experience of pain. These gaps are further amplified in the case of pediatric chronic pain due to a lack of basic/translational research. The team of basic scientists and clinician scientists is uniquely positioned to perform human pediatric studies integrating functional neuroimaging with quantitative sensory testing and psychological assessments to delineate brain systems engaged during chronic pain. The study will examine four distinct chronic pain syndromes: migraine, complex regional pain syndrome, functional abdominal pain, and musculoskeletal pain. The study seeks to 1) Identify shared and distinct brain systems engaged by different forms of pediatric chronic pain, 2) Determine if predictors of recovery differ across different chronic pain conditions, 3) Delineate brain systems associated with the spread of pain. To accomplish these aims, the study will recruit 400 patients with chronic pain and 100 healthy participants (age range 10-17). The study will follow all participants longitudinally for 1 year after initiation of treatment to assess the degree of recovery and spread of pain. This basic science investigation will provide a critical foundation of basic knowledge for future clinical trials of diagnostic markers for different forms of chronic pain and for the development of new treatments for chronic pain.

03

Conditions studied

  • Migraine in Children
  • Complex Regional Pain Syndromes
  • Musculoskeletal Pain
  • Functional Abdominal Pain Syndrome
  • Fibromyalgia

Keywords

  • chronic pain
04

Who can participate

Ages eligible
10 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients will need a diagnosis of a chronic pain derived congruent with ICD-11 criteria related to headache (migraine, daily headache), abdominal (FAPD), localized MSK (single limb/joint, low back or chest pain), diffuse MSK (widespread MSK pain), or CRPS
  • If on medications, they need to be on stable doses of prescribed pain and/or psychiatric medications for 4 weeks before the baseline study visit.
  • Male or female, age 10 -17 (inclusive)
  • English speaking, able to complete interviews and questionnaires in English

Exclusion criteria

Exclusion Criteria:

  • Weight/size incompatible with MRI scanner
  • Orthodontic braces, metallic or electronic implants, or other metal objects in the body which obscure or interfere with the MRI, or pose a risk from heating, movement, or malfunction in the MRI environment
  • Claustrophobia
  • Youth who are pregnant
  • Any comorbid rheumatic disease, diagnosis of epilepsy, other neurological diseases, or medical condition (e.g. diabetes, cancer, IBD)
  • Present psychiatric disease as defined by DSM IV (e.g. psychosis, bipolar disorder, major depression, generalized anxiety disorder), alcohol or drug dependence, or documented developmental delays or impairments (e.g., autism, cerebral palsy, ADHD, or mental retardation) that, in the opinion of the investigator, would interfere with adherence to study requirements or safe participation in the study
  • Skin conditions or past skin damage on the arms or legs in or near sites of sensory testing
  • Outside the age range (9 years old or younger; 18 years or older) at the time of consent
  • History of > 1 month opioid treatment.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
255 participants (estimated)

Study arms

  • Experimental
    Healthy Controls

    Healthy controls with no history of chronic pain.

    Other: Multisensory Task · Other: Graphesthesia · Other: Divided attention

  • Experimental
    Headache and Migraine

    Individuals who have migraine with headaches.

    Other: Multisensory Task · Other: Graphesthesia · Other: Divided attention

  • Experimental
    Functional Abdominal Pain Disorder (FAPD)

    Individuals who have functional abdominal pain disorder.

    Other: Multisensory Task · Other: Graphesthesia · Other: Divided attention

  • Experimental
    Localized and Diffuse/Widespread Musculoskeletal Pain (MSK)

    Individuals with chronic musculoskeletal pain.

    Other: Multisensory Task · Other: Graphesthesia · Other: Divided attention

  • Experimental
    Complex Regional Pain Syndrome (CRPS)

    Individuals with complex regional pain syndrome.

    Other: Multisensory Task · Other: Graphesthesia · Other: Divided attention

Interventions

  • OtherMultisensory Task

    Reversing checkerboard, tones, and finger opposition.

  • OtherGraphesthesia

    Trace numbers on skin.

  • OtherDivided attention

    Divide attention between two noxious stimuli.

06

What researchers measure

Primary outcomes

  1. FMRI: BOLD resting connectivity of the amygdala

    BOLD resting connectivity of the amygdala

    Time frame: Baseline

  2. Resting Cerebral Blood Flow (CBF)

    CBF derived from resting arterial spin labeled MRI

    Time frame: Baseline

  3. FMRI: Multisensory task activity

    BOLD activation during multisensory task

    Time frame: Baseline

  4. FMRI: Spatial task activity

    BOLD activation during spatial summation and divided attention

    Time frame: Baseline

  5. FMRI: BOLD resting connectivity of the posterior parietal cortex

    BOLD resting connectivity of the posterior parietal cortex

    Time frame: Baseline

  6. FMRI: Graphesthesia Activation

    BOLD activation during graphesthesia task

    Time frame: Baseline

  7. Pain Ratings

    Visual analog scale (VAS) ratings of pain intensity and pain unpleasantness. The VAS is a scale of 0-10, with higher scores indicating a worse outcome.

    Time frame: Baseline

  8. Pain Ratings

    Visual analog scale (VAS) ratings of pain intensity and pain unpleasantness. The VAS is a scale of 0-10, with higher scores indicating a worse outcome.

    Time frame: 1 Year Followup

  9. Spatial Distribution of Pain

    Body map assessment of location of pain

    Time frame: Baseline

  10. Spatial Distribution of Pain

    Body map assessment of location of pain

    Time frame: 1 Year Followup

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Data That Will Be Shared: Data sharing represents a critical dimension of the proposed research. The data will be quite complex with psychological, psychophysical, demographic information collected outside of the scanner, and multiple modalities of MRI information collected during scanning. Accordingly, this rich dataset can be utilized for many secondary analyses. All modalities of data will be shared, with raw data included. Formatting of Data to Facilitate Sharing: As data is acquired, it will be named and placed into directory structures according to the BIDS standard (Brain Imaging Database Structure: http://bids.neuroimaging.io/). This standard accommodates all types of neuroimaging data to be acquired in the present proposal, and also allows for the inclusion of non-neuroimaging data such as psychological, psychophysical, and demographic information. Importantly, when data is in this format, it can be readily shared within OpenFMRI and other data warehouses

Supporting information: Statistical analysis plan

Time frame: Data will be made available after publication of key papers and will be permanently available with no expiration date.

Access criteria: After publication of key papers, data will be freely available for all researchers.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Jun 2027, 49 months after the start.

Of 66 non-industry interventional studies with no phase under Complex Regional Pain Syndromes, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 60. This study's planned 49 months is above that.

Counting every sponsor, half of 67 studies reached it within 24 months; a quarter within 14 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2023
First posted
Apr 18, 2023
StartActual
May 1, 2023
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Jun 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05814497
Responsible party
Robert Coghill (Professor, Children's Hospital Medical Center, Cincinnati) — Principal investigator
First posted
Apr 18, 2023
Start date
May 1, 2023
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jun 5, 2026

Study contacts

Catherine Jackson, MSc
Contact
Catherine.Jackson@cchmc.org
5136360669
Hannah Schildmeyer, BS
Contact
Hannah.Schildmeyer@cchmc.org
Robert Coghill, PhD
principal investigator · Children's Hospital Medical Center, Cincinnati

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion